Pharma-Bio Serv (PBSV) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 5.32% |
| Oct 31, 2025 | -30.14% |
| Jul 31, 2025 | 8.78% |
| Apr 30, 2025 | -75.74% |
| Jan 31, 2025 | 34.93% |
| Oct 31, 2024 | -18.58% |
| Jul 31, 2024 | 46.36% |
| Apr 30, 2024 | -53.34% |
| Jan 31, 2024 | -75.14% |
| Oct 31, 2023 | 49.81% |
| Jul 31, 2023 | -38.55% |
| Apr 30, 2023 | 40.95% |
| Jan 31, 2023 | -49.36% |
| Oct 31, 2022 | -15.75% |
| Jul 31, 2022 | 32.80% |
| Apr 30, 2022 | -17.82% |
| Jan 31, 2022 | -82.81% |
| Oct 31, 2021 | 44.18% |
| Jul 31, 2021 | 24.60% |
| Apr 30, 2021 | -99.95% |
| Jan 31, 2021 | 47.01% |
| Oct 31, 2020 | -17.49% |
| Jul 31, 2020 | 38.45% |
| Apr 30, 2020 | 20.67% |
| Jan 31, 2020 | -83.04% |
| Jul 31, 2019 | -21.57% |
| Apr 30, 2019 | 18.71% |
| Jan 31, 2019 | -16.45% |
| Oct 31, 2018 | -19.82% |
| Jul 31, 2018 | 22.69% |
| Apr 30, 2018 | -36.87% |
| Jan 31, 2018 | 23.91% |
| Oct 31, 2017 | -17.34% |
| Jul 31, 2017 | -19.90% |
| Apr 30, 2017 | -37.50% |
| Jan 31, 2017 | 2.96% |
| Oct 31, 2016 | -18.37% |
| Jul 31, 2016 | -19.28% |
| Apr 30, 2016 | -22.23% |
| Jan 31, 2016 | -43.62% |
| Oct 31, 2015 | 18.75% |
| Jul 31, 2015 | 8.16% |